13 results on '"Mannaerts, Guido"'
Search Results
2. Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity
- Author
-
van Mil, Stefanie R., Biter, L. Ulas, van de Geijn, Gert-Jan M., Birnie, Erwin, Dunkelgrun, Martin, IJzermans, Jan N. M., van der Meulen, Noelle, Mannaerts, Guido H. H., and Castro Cabezas, Manuel
- Published
- 2018
- Full Text
- View/download PDF
3. Results of Implementing an Enhanced Recovery After Bariatric Surgery (ERABS) Protocol
- Author
-
Mannaerts, Guido H. H., van Mil, Stefanie R., Stepaniak, Pieter S., Dunkelgrün, Martin, de Quelerij, Marcel, Verbrugge, Serge J., Zengerink, Hans F., and Biter, L. Ulas
- Published
- 2016
- Full Text
- View/download PDF
4. Pulmonary Function Testing and Complications of Laparoscopic Bariatric Surgery
- Author
-
van Huisstede, Astrid, Biter, Laser Ulas, Luitwieler, Ronald, Castro Cabezas, Manuel, Mannaerts, Guido, Birnie, Erwin, Taube, Christian, Hiemstra, Pieter S., and Braunstahl, Gert-Jan
- Published
- 2013
- Full Text
- View/download PDF
5. Laparoscopic Sleeve Gastrectomy with an Extensive Posterior Mobilization: Technique and Preliminary Results
- Author
-
Gadiot, Ralph P. M., Biter, Lacer Ulas, Zengerink, Hans J. F., de Vos tot Nederveen Cappel, Robert J., Elte, Jan Willem F., Castro Cabezas, Manuel, and Mannaerts, Guido H. H.
- Published
- 2012
- Full Text
- View/download PDF
6. Laparoscopic Sleeve Gastrectomy versus Gastric Bypass in Late Adolescents: What Is the Optimal Surgical Strategy for Morbid Obesity?
- Author
-
van Mil, Stefanie Ramona, Biter, Laser Ulas, Grotenhuis, Brechtje Aleid, Zengerink, Johannes Franciscus, Huib Mannaerts, Guido Hein, and Mannaerts, Guido Hein Huib
- Subjects
MORBID obesity ,LAPAROSCOPY ,GASTRECTOMY ,GASTRIC bypass ,BARIATRIC surgery ,DISEASES in teenagers ,THERAPEUTICS ,COMPARATIVE studies ,RESEARCH methodology ,MEDICAL cooperation ,QUALITY of life ,RESEARCH ,WEIGHT loss ,EVALUATION research ,TREATMENT effectiveness ,RETROSPECTIVE studies - Abstract
Introduction Interest in bariatric surgery in adolescents is increasing, because adolescent obesity equals increased health risks in adult life. To define the preferred procedure in adolescents, this study compares outcomes of LSG and LRYGB in late adolescents in our center. Materials and methods Data on baseline characteristics, operative details, and follow-up were collected retrospectively in all patients (age 18-20 years) who underwent LSG or LRYGB in our clinic. Outcomes were analyzed using nonparametric tests. Results Total 65 adolescents (54 females; median age 19 years) were included, 45 patients underwent LSG, and 20 underwent LRYGB.Significant differences in %EWL were observed at 2-year follow-up; 81.0% in LRYGB (n = 11) versus 96.8% in LSG (n = 23), p = 0.007. No differences were observed in postoperative mortality, complication rate, and resolution of comorbidities between both procedures. Discussion LSG showed significant better results than LRYGB in terms of %EWL after 2 years in this selected group of late adolescents. Considering these results in LSG patients and the theoretical advantages of LSG (normal diet options, preservation of an intact GI-tract, less vitamin disturbances, and better quality of life), LSG may be an appropriate bariatric technique to perform in morbidly obese adolescents. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
7. Long-Term Results of Laparoscopic Sleeve Gastrectomy for Morbid Obesity: 5 to 8-Year Results.
- Author
-
Gadiot, Ralph, Biter, L., Mil, Stefanie, Zengerink, Hans, Apers, J., and Mannaerts, Guido
- Subjects
LAPAROSCOPIC surgery ,GASTRECTOMY ,MORBID obesity ,SLEEP apnea syndromes ,TYPE 2 diabetes - Abstract
Introduction: Although long-term results of sleeve gastrectomy (LSG) remain scarce in the literature, its popularity as a stand-alone procedure has accounted for a global increase in LSG performance. In this retrospective study, the authors present 5 to 8-year follow-up results in terms of weight loss, failure/revision rate, and comorbidity resolution from a single center. Materials and Methods: A prospectively maintained database was reviewed for patients who underwent LSG between 2007 and 2010. Data analysis on weight loss, comorbid conditions, revision surgery, and mortality was conducted. Results: Median percentage excess BMI loss (%EBMIL) was 59.0, and 53.9 %, and median percentage total weight loss (%TWL) was 25.1, and 22.9 % at 5 and 8 years, respectively. Revision to gastric bypass due to insufficient weight loss or gastroesophageal reflux disease (GERD) was performed in 42 patients (15.2 %). Resolution of comorbid condition was achieved in 91 % of patients with obstructive sleep apnea syndrome (OSAS), 68 % of patients with type 2 diabetes (T2DM), 53 % of patients with hypertension, and 25 % of patients with dyslipedemia. Loss to follow-up rate was 45 % at 5 years, 28 % at 6 years, 23 % at 7 years, and 13 % at 8 years. Conclusion: This study adds to the currently available data confirming the LSG to be a safe and effective procedure at long term. Data from high-volume studies are needed to establish the definite role of the LSG in the spectrum of bariatric procedures. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
8. Study protocol of the DUCATI-study: a randomized controlled trial investigating the optimal common channel length in laparoscopic gastric bypass for morbid obese patients.
- Author
-
Gadiot, Ralph P. M., Grotenhuis, Brechtje A., Biter, L. Ulas, Dunkelgrun, Martin, Zengerink, Hans J. J., Feskens, Pierre B. G. M., and Mannaerts, Guido H. H.
- Subjects
OBESITY treatment ,PREVENTION of obesity ,WEIGHT loss -- Social aspects ,OVERWEIGHT persons ,MALNUTRITION ,MANAGEMENT ,HEALTH - Abstract
Background: Morbid obesity has become one of the most frequent chronic medical disorders in Western countries, affecting 1.5-2 % of the Dutch population. Currently, the laparoscopic Roux-Y gastric bypass is considered to be the most effective bariatric treatment option for morbid obesity as it results in adequate weight loss and a significant decrease in comorbidity. Although this technique has been applied for years, the optimal lengths of the three bowel limbs (alimentary limb, biliopancreatic limb, and common channel) in order to achieve maximal percentage excess weight loss with minimal side effects (i.e. malabsorption symptoms), are unknown. As 'normal'' sized gastric bypasses achieve an average of 60 - 80 % excess weight loss after one year, one could hypothesize that afferent limb lengths should be longer in order to reduce the common channel length, thereby improving outcome in terms of excess weight loss. The aim of the current study is to investigate the effect of the length of the common channel in gastric bypass surgery for morbid obesity. In this randomized controlled trial the very long Roux limb gastric bypass will be compared to the standard gastric bypass, in order to conclude which option is the optimal therapeutic strategy in the morbidly obese patient. Methods/design: In this multicentre trial patients will be randomized either to a very long Roux limb gastric bypass with a fixed common channel length of 100 cm, or to a standard gastric bypass with a variable common channel length. The primary objective is to evaluate whether the very long Roux limb gastric bypass is superior in terms of percentage excess weight loss after one year follow-up compared to the standard gastric bypass. Secondary endpoints are quality-of-life, cure /improvement of obesity related comorbidity, complications, malnutrition, re-admission rate, and re-operation rate. Discussion: We hypothesize that our proposed distal LRYGB will provide for improved results concerning % EWL with an acceptable rate of (metabolic) complications. Our main point of interest is to determine if the distal LRYGB is a superior alternative to standard LRYGB in terms of percentage excess weight loss and to put more focus on the role of the common channel. Therefore we will perform this randomized controlled trial comparing both techniques, with % EWL as a primary outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
9. Pulmonary Function Testing and Complications of Laparoscopic Bariatric Surgery.
- Author
-
Huisstede, Astrid, Biter, Laser, Luitwieler, Ronald, Castro Cabezas, Manuel, Mannaerts, Guido, Birnie, Erwin, Taube, Christian, Hiemstra, Pieter, and Braunstahl, Gert-Jan
- Subjects
PULMONARY function tests ,BARIATRIC surgery ,SURGICAL complications ,MORBID obesity ,SPIROMETRY - Abstract
Background: Obesity is associated with respiratory symptoms and impaired pulmonary function, which could increase the risk of complications after bariatric surgery. The purpose of this study is to assess the relationship between pulmonary function parameters before, and the risk of complications after, laparoscopic bariatric surgery. Methods: This prospective study included patients (age 18-60, BMI >35 kg/m), who were eligible for bariatric surgery. Spirometry was performed in all patients. Complications up to 30 days after bariatric surgery were recorded. Results: Four hundred eighty-five patients were included (304 laparoscopic sleeve gastrectomy, 181 laparoscopic gastric bypass). There were 53 complications (8 pulmonary, 27 surgical, 14 infectious, 4 other) in 50 patients (10 %). There were 35 re-admissions (7.2 %), and 17 re-laparoscopies (3.5 %). Subjects with and without complications did not differ significantly with respect to demographics, weight, BMI, abdominal circumference or fat percentage. Subjects with complications had a significantly lower mean FEV (mean 86.9 % predicted) and FVC (95.6 % predicted) compared to patients without complications (95.9 % predicted, p = 0.005, and 100.1 % predicted, p = 0.045, respectively). After adjustment for age, gender, BMI, and smoking, abnormal spirometry value remained the single predictive covariable of postoperative complications: FEV/FVC <70 % adjusted OR 3.1 (95%CI 1.4-6.8, p = 0.006) and ΔFEV ≥12 % adjusted OR 2.9 (95 %CI 1.3-6.6, p = 0.010). Conclusions: The risk of pulmonary complications after laparoscopic bariatric surgery is low. However, subjects with abnormal spirometry test results have a threefold risk of complications after laparoscopic bariatric surgery. Preoperative pulmonary function testing might be useful to predict the risk of complications of laparoscopic bariatric surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
10. Treatment of giant hiatal hernia by laparoscopic Roux-en-Y gastric bypass.
- Author
-
Duinhouwer, Lucia E., Biter, L. Ulas, Wijnhoven, Bas P., and Mannaerts, Guido H.
- Abstract
Introduction Obesity is a risk factor for hiatal hernia. In addition, much higher recurrence rates are reported after standard surgical treatment of hiatal hernia in morbidly obese patients. Laparoscopic Roux-en-Y gastric bypass (LRYGB) is an effective surgical treatment for morbid obesity and is known to effectively control symptoms of gastroesophageal reflux (GERD). Case presentation Two patients suffering from giant hiatal hernias where a combined LRYGB and hiatal hernia repair (HHR) with mesh was performed are presented in this paper. There were no postoperative complications and at 1 year follow-up, there was no sign of recurrence of the hernia. Discussion The gold standard for all symptomatic reflux patients is still surgical correction of the paraesophageal hernia, including complete reduction of the hernia sac, resection of the sac, hiatal closure and fundoplication. However, HHR outcome is adversely affected by higher BMI levels, leading to increased HH recurrence rates in the obese. Conclusion Concomitant giant hiatal hernia repair with LRYGB appears to be safe and feasible. Moreover, LRYGB plus HHR appears to be a good alternative for HH patients suffering from morbid obesity as well than antireflux surgery alone because of the additional benefit of significant weight loss and improvement of obesity related co-morbidity. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
11. The effect of sex and menopause on carotid intima‐media thickness and pulse wave velocity in morbid obesity.
- Author
-
Mil, Stefanie R., Biter, L. Ulas, Geijn, Gert Jan M., Birnie, Erwin, Dunkelgrun, Martin, Ijzermans, Jan N. M., Meulen, Noelle, Mannaerts, Guido H. H., and Castro Cabezas, Manuel
- Subjects
CAROTID intima-media thickness ,MORBID obesity ,DISEASE risk factors ,GENDER ,BODY mass index ,WAIST circumference - Abstract
Background: Women are relatively protected from cardiovascular disease compared with men. Since morbid obesity is an independent risk factor for cardiovascular disease, the current study investigated whether the association between sex and cardiovascular risk factors and outcomes can be demonstrated in subjects suffering from morbid obesity. Materials and methods: Two hundred subjects enrolled in a study on cardiovascular risk factors in morbid obesity underwent extensive laboratory screening, carotid intima‐media thickness (cIMT) and pulse wave velocity (PWV) measurements. Gender differences were analysed using univariate and multivariable linear regression models. In addition, the effect of menopause on cIMT and PWV was analysed. Results of these models were reported as B coefficients with 95% confidence intervals. Results: The group consisted of 52 men and 148 women, with a mean age of 41 (±11.8) years and a mean body mass index (BMI) of 42.7 (±5.2) kg/m2. Both, cIMT and PWV were significantly higher in men than in women, although the difference in cIMT disappeared after adjustment for covariables such as waist circumference, age, high‐density lipoprotein cholesterol and mean arterial pressure. PWV was associated with sex after adjustments for covariables in morbidly obese patients. Postmenopausal women had significantly increased cIMT and PWV when compared with premenopausal women. Conclusion: Sex differences in PWV persist in subjects suffering from morbid obesity. However, no difference was found in cIMT between morbidly obese men and women after adjustment for classic cardiovascular risk factors. Premenopausal morbidly obese women are protected for cardiovascular disease when compared with postmenopausal morbidly obese women. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
12. Systemic Inflammation and Lung Function Impairment in Morbidly Obese Subjects with the Metabolic Syndrome.
- Author
-
van Huisstede, Astrid, Castro Cabezas, Manuel, Birnie, Erwin, van de Geijn, Gert-Jan M., Rudolphus, Arjan, Mannaerts, Guido, Njo, Tjin L., Hiemstra, Pieter S., and Braunstahl, Gert-Jan
- Subjects
- *
ASTHMA risk factors , *GASTROESOPHAGEAL reflux diagnosis , *HEART disease risk factors , *LUNG diseases , *LUNG physiology , *SLEEP apnea syndromes , *SMOKING , *METABOLIC syndrome diagnosis , *BARIATRIC surgery , *ANTHROPOMETRY , *ASTHMA , *BLOOD pressure measurement , *CHI-squared test , *CHOLESTEROL , *INFLAMMATION , *LIPOPROTEINS , *MEDICAL screening , *METABOLISM , *OBESITY , *PREOPERATIVE care , *PULMONARY function tests , *T-test (Statistics) , *U-statistics , *DATA analysis , *BODY mass index , *MORBID obesity , *CROSS-sectional method , *VITAL capacity (Respiration) , *DISEASE complications , *DIAGNOSIS , *DISEASE risk factors - Abstract
Background. Obesity and asthma are associated. There is a relationship between lung function impairment and the metabolic syndrome. Whether this relationship also exists in the morbidly obese patients is still unknown. Hypothesis. Low-grade systemic inflammation associated with the metabolic syndrome causes inflammation in the lungs and, hence, lung function impairment. Methods. This is cross-sectional study of morbidly obese patients undergoing preoperative screening for bariatric surgery. Metabolic syndrome was assessed according to the revised NCEP-ATP III criteria. Results. A total of 452 patients were included. Patients with the metabolic syndrome (n = 293) had significantly higher blood monocyte (mean 5.3 versus 4.9, P = 0.044) and eosinophil percentages (median 1.0 versus 0.8, P = 0.002), while the total leukocyte count did not differ between the groups. The FEV1/FVC ratio was significantly lower in patients with the metabolic syndrome (76.7% versus 78.2%, P = 0.032). Blood eosinophils were associated with FEV1/FVC ratio (adj. B .0.113, P = 0.018). Conclusion. Although the difference in FEV1/FVC ratio between the groups is relatively small, in this cross-sectional study, and its clinical relevance may be limited, these data indicate that the presence of the metabolic syndrome may influence lung function impairment, through the induction of relative eosinophilia. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
13. Complement C3 as a predictor for metabolic syndrome in morbid obesity.
- Author
-
Mil, Stefanie Van, Biter, Ulas, Van De Geijn, Gert-Jan, Mannaerts, Guido, and Castro Cabezas, Manuel
- Subjects
- *
COMPLEMENT (Immunology) , *METABOLIC syndrome , *MORBID obesity , *HYPERLIPIDEMIA , *CARDIOVASCULAR diseases risk factors - Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.